Leila Souabni Leila Dridi Kawther Ben Abdelghani Selma Kassab Selma Chekili Ahmed Laater Leith Zakraoui
10.11604/pamj.2014.17.94.3386
Pan Afr Med J
2014 Feb 7;17:94.
adult-onset still′s disease adalimumab hemophagocytic syndrome macrophage activation syndrome
CC BY
https://pubmed.ncbi.nlm.nih.gov/25018831/
Anti-Inflammatory Agents / adverse effects Antibodies, Monoclonal, Humanized / adverse effects Macrophage Activation Syndrome / chemically induced Macrophage Activation Syndrome / diagnosis Still's Disease, Adult-Onset / drug therapy
Anti-Inflammatory Agents / adverse effects Antibodies, Monoclonal, Humanized / adverse effects Macrophage Activation Syndrome / chemically induced Macrophage Activation Syndrome / diagnosis Still's Disease, Adult-Onset / drug therapy Case Reports Adalimumab Adult Female Humans Anti-Inflammatory Agents Antibodies, Monoclonal, Humanized Adalimumab
PMC4081143
25018831
Possible macrophage activation syndrome following initiation of adalimumab in a patient with adult-onset Still's disease
2014